Skip to search formSkip to main contentSkip to account menu

entecavir 0.5 MG Oral Tablet

Known as: entecavir 0.5 mg ORAL TABLET, FILM COATED [Entecavir], ENTECAVIR 0.5MG TAB, ENTECAVIR ANHYDROUS 0.5 mg ORAL TABLET 
National Institutes of Health

Related topics

Related topics

31 relations

Broader (1)

Antiviral Agents
Calcium CarbonateCarboxymethylcellulose SodiumCrospovidoneHepatitis B

Narrower (1)

entecavir 0.5 MG Oral Tablet [Baraclude]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Gastrointestinale Tumoren: Neues zur Checkpoint-Hemmung
Review
2016
Review
2016
The efficacy of tenofovir-based therapy in patients showing suboptimal response to entecavir-adefovir combination therapy
Background/Aims: Before tenofovir (TDF) become available in South Korea, combination therapy with entecavir (ETV) and adefovir… 
2014
2014
Finite entecavir therapy is a feasible alternative to indefinite therapy
laxis, BCLC classification and liver failure as measured by ChildPugh score were independent predictors of death. We agree with… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)